Mark Worscheh

Verified
Manager and President at Fannin AdvisoryListed on SEC Form ADVHouston, United States
Claim this profile
Sign up to save
Cold

Check Size

Not yet known

Reliability Score

🎯100% of deals in Healthcare

Investment Timeline

Goldenrod Therapeutics
Board seat (SEC Form D)Source
Since Jun 2026
Company last raised Jun 2026
Brevitest Technologies
Board seat (SEC Form D)Source
Since Dec 2020
Company last raised Dec 2021
Fannin Partners
Board seat (SEC Form D)Source
Since Dec 2018
Company last raised Jul 2019
Pulmotect
Board seat (SEC Form D)Source
Since May 2016
Company last raised Sep 2024

Portfolio Breakdown

By Sector

Healthcare4 deals · 100%

By Stage

4 tracked deals1 sector · 0 stages

Deal Velocity

Avg Deals / Year
0.4
Avg Deal Size
Unknown
Largest Deal
Goldenrod Therapeutics
Unknown
YoY Trend
Accelerating

Deals Per Year

1
16
0
17
1
18
0
19
1
20
0
21
0
22
0
23
0
24
0
25
1
26
4 total deals tracked2016–2026

Investment Activity Map

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Less
More

Current Fund Status

Fund Name
Fannin Allterum Holdings II, LLC
Reported Size
$4.2M

Co-Investors

No co-investment data available yet.

Warm Intro Paths

Sign in to discover warm intro paths

Sign in